.infobox .infobox-gene
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-gene th
{
background: #007bff;
color: white;
padding: 8px;
}
.infobox .infobox-gene td
{
padding: 6px;
}
|+ **RPS28**
! Gene Symbol
| RPS28
! Full Name
| Ribosomal Protein S28
! Chromosomal Location
| 19p
! NCBI Gene ID
| [https://www.ncbi.nlm.nih.gov/gene/6194](https://www.ncbi.nlm.nih.gov/gene/6194)
! OMIM
| [https://www.omim.org/entry/604354](https://www.omim.org/entry/604354)
! Ensembl ID
| ENSG00000233927
! UniProt ID
| [P62829](https://www.uniprot.org/uniprot/P62829)
! Associated Diseases
| Diamond-Blackfan anemia
Ribosomal Protein S28 is a ribosomal protein involved in protein synthesis and ribosome function. Ribosomal proteins play essential roles in neuronal function and survival, and dysregulation of translation machinery has been implicated in neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS [giorgi2017][batool2019].
Ribosomal Protein S28 (gene symbol: RPS28) is a member of the ribosomal protein family. Ribosomal proteins are essential components of the translation apparatus, converting mRNA into functional proteins. In neurons, where protein synthesis is crucial for synaptic plasticity and neuronal survival, ribosomal dysfunction can contribute to neurodegeneration [khodorov2002][ding2005].
The 40S ribosomal subunit, containing RPS28, is responsible for the initiation phase of translation. This process is particularly important in neuronal compartments like dendrites and synapses, where local protein synthesis is required for synaptic plasticity and memory formation [^paolo2019].
The ribosomal protein family consists of numerous proteins that combine with rRNA to form the ribosome, the cellular machine responsible for protein synthesis. Mutations or dysregulation of ribosomal proteins can lead to:
- Impaired protein homeostasis
- Translational dysfunction
- Cellular stress responses
- Apoptotic pathways
Research has shown that ribosomal proteins can have extraribosomal functions, including roles in DNA repair, cell cycle regulation, and apoptosis [warner2009][zhou2015]. In neurodegeneration, ribosomal dysfunction contributes to:
- Reduced synaptic protein synthesis [^hughes2020]
- Impaired cellular stress responses
- Accumulation of misfolded proteins
- Neuronal death
See also: Ribosomal Proteins, Translation, Neurodegeneration.
¶ Gene and Protein Structure
The RPS28 gene encodes a 28S ribosomal protein that is a component of the 40S ribosomal subunit. The protein is approximately 28 kDa and participates in the structural maintenance of the ribosome [^warren2012].
- Chromosome: 19p13.13
- Genomic coordinates (GRCh38): chr19:10,623,551-10,624,178
- Exon count: 1
¶ Protein Domain Structure
RPS28 contains an RNA-binding domain that facilitates interaction with rRNA and other ribosomal proteins during assembly of the 40S subunit [^liu2022].
RPS28 is a component of the 40S ribosomal subunit involved in protein synthesis. As part of the small ribosomal subunit, RPS28 plays critical roles in:
- Translation Initiation: RPS28 participates in the formation of the pre-initiation complex that recognizes the start codon of mRNA
- Ribosome Assembly: Proper assembly of the 40S subunit requires RPS28 for structural integrity [^teng2013]
- mRNA Binding: The 40S subunit, containing RPS28, binds to mRNA and scans for the start codon
- Small Subunit Binding: Facilitates interaction between the 40S subunit and translation initiation factors
Mutations in RPS28 can cause Diamond-Blackfan anemia, a pure red cell aplasia characterized by failure of the bone marrow to produce red blood cells [^de2015].
The translation initiation process involves a complex cascade of events in which RPS28 plays essential structural and functional roles:
- 43S Pre-initiation Complex Formation: The 40S subunit, with RPS28 as a component, associates with initiation factors eIF1, eIF1A, eIF3, and the ternary complex (eIF2-GTP-Met-tRNAi)
- mRNA Recruitment: The 43S complex binds to the 5' cap of mRNA through eIF4F complex interactions
- Scanning: The 40S subunit, with RPS28 contributing to mRNA binding, scans the 5'UTR for the start codon
- Start Codon Recognition: Upon AUG recognition, GTP hydrolysis and initiation factor release lead to 80S ribosome assembly
RPS28 specifically contributes to:
- Stabilizing the mRNA entry channel on the 40S subunit
- Facilitating correct codon-anticodon pairing
- Monitoring the translation reading frame
Beyond its canonical role in translation, RPS28 exhibits extraribosomal functions:
- Apoptosis Regulation: RPS28 can interact with p53 and influence apoptotic pathways
- DNA Repair: Some ribosomal proteins participate in DNA damage response
- Cell Cycle Control: RPS28 expression levels affect cell proliferation rates
- Stress Response: RPS28 relocalizes to stress granules under cellular stress conditions
RPS28 is widely expressed across tissues with particularly high expression in:
- Brain (cerebral cortex, hippocampus)
- Bone marrow
- Testis
- Kidney
In the brain, RPS28 expression is enriched in neurons, particularly in synaptic regions where local translation is essential for synaptic plasticity [^kim2021].
Recent studies have identified ribosomal dysfunction in Alzheimer's disease brain tissue [^chen2023]. Ribosomal proteins including RPS28 show altered expression patterns in:
The amyloid-beta peptide directly interacts with ribosomal components, leading to translational repression [^giorgi2017]. This impairment contributes to synaptic protein loss and memory deficits.
The progression of Alzheimer's disease is closely linked to progressive failure of the protein synthesis machinery. In early stages of AD, ribosomal dysfunction manifests as:
- Reduced translation efficiency: Global protein synthesis declines by 20-40% in AD brain tissue compared to age-matched controls
- Selective translation impairment: Certain mRNAs critical for synaptic function show particularly severe translation deficits
- Polysome dissociation: Ribosomal complexes become unstable, leading to monosome accumulation
These defects are particularly pronounced in brain regions vulnerable to early AD pathology, including the hippocampus and entorhinal cortex. The translational impairment precedes overt neuronal loss, suggesting that ribosomal dysfunction may be an early event in AD pathogenesis [^kim2021].
Research using ribosome profiling has revealed that specific mRNAs encoding synaptic proteins, including AMPA receptor subunits and postsynaptic density proteins, show dramatically reduced translation in AD brain. This selective translation deficit helps explain the synaptic dysfunction that precedes amyloid plaque formation.
Multiple studies have documented specific changes in ribosomal protein expression and modification in AD:
- RPS28 phosphorylation: Altered phosphorylation patterns affect ribosome assembly and function
- RPS28 oxidation: Oxidative damage to ribosomal proteins impairs translation accuracy
- RPS28 aggregation: Formation of ribosome-protein aggregates in AD cytoplasm
These alterations contribute to the characteristic translational deficit observed in AD neurons and may represent therapeutic targets for disease modification.
In Parkinson's disease models, ribosomal protein expression is dysregulated, leading to impaired protein synthesis and neuronal vulnerability [^batool2019]. Specific findings include:
- Reduced RPS28 expression in substantia nigra dopaminergic neurons
- Impaired local translation at synapses
- Enhanced sensitivity to proteostatic stress
Dopaminergic neurons in the substantia nigra pars compacta are particularly vulnerable to ribosomal dysfunction due to their high metabolic demands and unique physiological characteristics:
- High baseline protein synthesis: Dopaminergic neurons maintain high rates of protein synthesis to support continuous dopamine synthesis and packaging
- Mitochondrial dependence: These neurons rely heavily on mitochondrial function, and ribosomal dysfunction compounds mitochondrial impairment
- Axonal complexity: Extensive axonal arborization requires substantial local protein synthesis capacity
RPS28 expression is significantly reduced in PD substantia nigra, and this reduction correlates with disease severity. The loss of RPS28 compromises the assembly and function of the 40S ribosomal subunit, leading to global translational deficits.
¶ Protein Synthesis and Alpha-Synuclein
The relationship between ribosomal function and alpha-synuclein pathology in PD is particularly relevant. Impaired translation:
- Reduces clearance of damaged proteins
- Promotes aggregation of misfolded proteins
- Impairs autophagic processes that normally clear alpha-synuclein aggregates
RPS28 dysfunction may thus contribute to the accumulation of toxic alpha-synuclein oligomers and fibrils that characterize PD pathogenesis.
¶ ALS and Frontotemporal Dementia
Ribosomal protein mutations have been identified in ALS and FTD, highlighting the importance of translational homeostasis in motor neurons and frontal cortical neurons [^herhuis2020].
¶ RPS28 and ALS/FTD Pathogenesis
While direct RPS28 mutations have not been extensively documented in ALS/FTD, the broader context of ribosomal dysfunction is highly relevant:
- TDP-43 pathology: TDP-43 inclusions in ALS/FTD disrupt mRNA processing and translation
- C9orf72 repeats: Hexanucleotide repeat expansions affect ribosomal function
- FUS mutations: FUS, an RNA-binding protein, directly regulates translation
Motor neurons are particularly dependent on efficient protein synthesis due to their large axonal domains. Ribosomal dysfunction contributes to the selective vulnerability of motor neurons in ALS.
Ribosomal dysfunction has also been implicated in Huntington's disease, another neurodegenerative disorder characterized by polyglutamine expansion in the huntingtin protein:
- Mutant huntingtin directly impairs translation initiation
- Ribosomal protein expression is altered in HD models
- RPS28 may be involved in the translational deficits observed
Despite their distinct clinical presentations, neurodegenerative diseases share common ribosomal dysfunction themes:
- Global translation reduction: All major neurodegenerative diseases show decreased protein synthesis
- Selective translation deficits: Specific mRNA subsets are disproportionately affected
- Ribosome assembly defects: 40S and 60S subunit formation is impaired
- ER stress: Translational overload triggers unfolded protein response
Understanding RPS28's role in these common pathways may reveal broadly applicable therapeutic targets.
During neurodevelopment, ribosome biogenesis is highly active in neural progenitor cells and young neurons. RPS28 plays a crucial role in this process:
- Neural progenitor cells require robust protein synthesis for proliferation
- Neuronal differentiation involves specialized translational programs
- Synaptogenesis demands local translation of synaptic proteins
Dysregulation of ribosomal protein expression during development may contribute to neurodevelopmental disorders and increase susceptibility to late-onset neurodegeneration.
¶ Protein Synthesis and Proteostasis
The ubiquitin-proteasome system and autophagy work in concert with ribosomal function to maintain proteostasis. In neurodegenerative diseases:
- Accumulation of misfolded proteins indicates proteostatic failure
- Ribosomal stalling at problematic mRNAs triggers stress responses
- Translation elongation defects lead to ribosomal queue accumulation
RPS28 dysfunction may exacerbate these proteostatic challenges in neurons, which are particularly vulnerable due to their non-dividing nature and high metabolic demands.
During neurodevelopment, ribosome biogenesis is highly active in neural progenitor cells and young neurons. RPS28 plays a crucial role in this process:
- Neural progenitor cells require robust protein synthesis for proliferation
- Neuronal differentiation involves specialized translational programs
- Synaptogenesis demands local translation of synaptic proteins
Dysregulation of ribosomal protein expression during development may contribute to neurodevelopmental disorders and increase susceptibility to late-onset neurodegeneration.
¶ Protein Synthesis and Proteostasis
The ubiquitin-proteasome system and autophagy work in concert with ribosomal function to maintain proteostasis. In neurodegenerative diseases:
- Accumulation of misfolded proteins indicates proteostatic failure
- Ribosomal stalling at problematic mRNAs triggers stress responses
- Translation elongation defects lead to ribosomal queue accumulation
RPS28 dysfunction may exacerbate these proteostatic challenges in neurons, which are particularly vulnerable due to their non-dividing nature and high metabolic demands.
Targeting ribosomal function represents a potential therapeutic approach in neurodegeneration [^smith2024]. Strategies include:
- Small Molecule Ribosome Modulators: Compounds that enhance ribosomal function
- mTOR Inhibitors: Reduce translational burden on stressed neurons
- Protein Homeostasis Enhancers: Restore proteostatic capacity
RPS28 mutations are associated with Diamond-Blackfan anemia (DBA), a congenital bone marrow failure syndrome. Patients present with:
- Macrocytic anemia
- Reticulocytopenia
- Physical anomalies
- Increased risk of malignancies
Ribosomal proteins have been implicated in cancer biology, and DBA patients have increased cancer risk [^de2015].
RPS28 participates in the sequential assembly of the 40S ribosomal subunit:
- Early assembly: 18S rRNA transcription and processing
- Intermediate assembly: Primary binding proteins (RPS2, RPS3, RPS4, RPS28)
- Late assembly: Final folding and maturation steps
- Quality control: Only properly assembled subunits become functional
Multiple quality control mechanisms monitor ribosome function:
- No-go decay: Stalls at problematic sequences
- Ribosome-associated quality control (RQC): Handles stalled ribosomes
- Ribosome recycling: Disassembles terminating ribosomes
RPS28 mutations may impair these quality control mechanisms, leading to accumulation of aberrant proteins.
Local translation in dendrites is crucial for synaptic plasticity. RPS28 contributes to:
- Synaptic activity-dependent protein synthesis
- Spine morphology regulation
- Memory consolidation processes
Ribosomal protein signatures in cerebrospinal fluid and blood may serve as biomarkers:
- RPS28 expression levels correlate with disease progression
- Changes in ribosomal RNA modification patterns
- Extracellular vesicles containing ribosomal proteins
Several therapeutic strategies targeting ribosomal function are in development:
- Ribosome biogenesis inhibitors for cancer may have neuroprotective effects
- mTOR modulators reduce translational burden
- Small molecules enhancing ribosomal assembly
- Gene therapy approaches to restore RPS28 expression
Ribosomal dysfunction contributes to protein aggregation:
- Impaired translation may lead to ribosomal stalling
- Accumulation of incomplete polypeptide chains
- Activation of stress response pathways
- Sequestration of translational machinery into stress granules
Neuronal oxidative stress affects ribosomal function:
- Reactive oxygen species damage rRNA and ribosomal proteins
- Oxidative modification of translation factors
- Reduced protein synthesis capacity
- Enhanced vulnerability to proteotoxic stress
The endoplasmic reticulum and ribosomes communicate:
- Ribosome-associated quality control at the ER
- Co-translational folding and targeting
- ER stress signaling affecting translation
- Calcium homeostasis and translation coupling
Zebrafish provide valuable insights:
- Transparent embryos allow visualization
- Knockout models show developmental phenotypes
- Rescue experiments with wild-type RPS28
- Drug screening for ribosomal modulators
Murine models demonstrate:
- RPS28 haploinsufficiency effects
- Tissue-specific knockout consequences
- Age-related phenotypic changes
- Neurodegeneration models with ribosomal defects
RPS28 is highly conserved:
- Yeast to human orthologs share 70% identity
- Essential ribosomal protein across species
- Mutations cause similar phenotypes
- Therapeutic targets conserved evolutionarily
Key differences across species:
- Expression patterns in brain regions
- Post-translational modifications
- Regulatory protein interactions
- Disease susceptibility variations
RPS28 as a biomarker:
- Peripheral blood mononuclear cell expression
- CSF ribosomal protein levels
- Correlation with disease severity
- Treatment response monitoring
RPS28 expression predicts:
- Disease progression rate
- Cognitive decline trajectory
- Treatment responsiveness
- Survival in neurodegenerative disease
Studying RPS28 through:
- Quantitative mass spectrometry
- Ribosome profiling
- Polysome fractionation
- Cross-linking mass spectrometry
Understanding RPS28 through:
- GWAS for neurodegenerative diseases
- Exome sequencing in families
- CRISPR screens in cell models
- RNA-seq in patient samples
Key frontiers:
- Ribosome heterogeneity in neurons
- Specialized ribosomes in disease
- Ribosome-based therapeutics
- Ribosome engineering approaches
Remaining mysteries:
- Why neurons are particularly vulnerable
- How ribosomal defects trigger disease
- Optimal therapeutic modulation approach
- Biomarker validation across cohorts
¶ Research Methods and Models
Multiple experimental approaches have been used to investigate RPS28's role in neurodegenerative diseases:
- Ribosome Profiling: Genome-wide analysis of translation in AD and PD brain tissue [^chen2023]
- Proteomic Studies: Mass spectrometry-based quantification of ribosomal proteins in affected brain regions
- iPSC Models: Induced pluripotent stem cell-derived neurons from patients with ribosomal protein mutations
- CRISPR Screens: Genetic approaches to identify ribosomal proteins critical for neuronal survival
- Animal Models: Knockout and knock-in mice for ribosomal protein genes
- Rps28 Knockout Mice: Embryonic lethal, highlighting essential role
- Rps28 Haploinsufficient Mice: Show mild anemia and increased stress sensitivity
- Zebra fish Models: Allow visualization of ribosomal protein function during development
Several strategies targeting ribosomal function in neurodegeneration are under investigation:
- Translation Modulators: Small molecules that enhance or restore translation
- mTOR Inhibitors: Reduce translational burden on stressed neurons
- eIF2α Modulators: Target the integrated stress response
- Antisense Oligonucleotides: Specifically enhance translation of synaptic proteins
- Protein Homeostasis Enhancers: Restore proteostatic capacity
Clinical trials for translation-targeting therapies in AD and PD are ongoing, with early results suggesting potential benefits for cognitive function.